205 related articles for article (PubMed ID: 15801487)
1. How representative are the surveillance, epidemiology, and end results (SEER) program cancer data of the United States?
Merrill RM; Dearden KA
Cancer Causes Control; 2004 Dec; 15(10):1027-34. PubMed ID: 15801487
[TBL] [Abstract][Full Text] [Related]
2. Representativeness of the surveillance, epidemiology, and end results program data: recent trends in cancer mortality rates.
Frey CM; McMillen MM; Cowan CD; Horm JW; Kessler LG
J Natl Cancer Inst; 1992 Jun; 84(11):872-7. PubMed ID: 1593655
[TBL] [Abstract][Full Text] [Related]
3. Building the infrastructure for nationwide cancer surveillance and control--a comparison between the National Program of Cancer Registries (NPCR) and the Surveillance, Epidemiology, and End Results (SEER) Program (United States).
Wingo PA; Jamison PM; Hiatt RA; Weir HK; Gargiullo PM; Hutton M; Lee NC; Hall HI
Cancer Causes Control; 2003 Mar; 14(2):175-93. PubMed ID: 12749723
[TBL] [Abstract][Full Text] [Related]
4. Cancer prevalence estimates based on tumour registry data in the Surveillance, Epidemiology, and End Results (SEER) Program.
Merrill RM; Capocaccia R; Feuer EJ; Mariotto A
Int J Epidemiol; 2000 Apr; 29(2):197-207. PubMed ID: 10817114
[TBL] [Abstract][Full Text] [Related]
5. Cancers of the upper aerodigestive tract in Ontario, Canada, and the United States.
Skarsgard DP; Groome PA; Mackillop WJ; Zhou S; Rothwell D; Dixon PF; O'Sullivan B; Hall SF; Holowaty EJ
Cancer; 2000 Apr; 88(7):1728-38. PubMed ID: 10738233
[TBL] [Abstract][Full Text] [Related]
6. Surveillance for cancers associated with tobacco use--United States, 1999-2004.
Stewart SL; Cardinez CJ; Richardson LC; Norman L; Kaufmann R; Pechacek TF; Thompson TD; Weir HK; Sabatino SA;
MMWR Surveill Summ; 2008 Sep; 57(8):1-33. PubMed ID: 18772853
[TBL] [Abstract][Full Text] [Related]
7. Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment.
Edwards BK; Brown ML; Wingo PA; Howe HL; Ward E; Ries LA; Schrag D; Jamison PM; Jemal A; Wu XC; Friedman C; Harlan L; Warren J; Anderson RN; Pickle LW
J Natl Cancer Inst; 2005 Oct; 97(19):1407-27. PubMed ID: 16204691
[TBL] [Abstract][Full Text] [Related]
8. The effect of multiple primary rules on population-based cancer survival.
Weir HK; Johnson CJ; Thompson TD
Cancer Causes Control; 2013 Jun; 24(6):1231-42. PubMed ID: 23558444
[TBL] [Abstract][Full Text] [Related]
9. Gender- and race-specific comparison of tobacco-associated cancer incidence trends in Florida with SEER regional cancer incidence data.
Lee DJ; Voti L; MacKinnon J; Koniaris LG; Fleming LE; Huang Y; Wohler B; Franceschi D; Dietz NA; Sherman R; Soler-Vilá H
Cancer Causes Control; 2008 Sep; 19(7):711-23. PubMed ID: 18322816
[TBL] [Abstract][Full Text] [Related]
10. Annual cancer incidence rates for Hispanics in the United States: surveillance, epidemiology, and end results, 1992-1996.
Canto MT; Chu KC
Cancer; 2000 Jun; 88(11):2642-52. PubMed ID: 10861444
[TBL] [Abstract][Full Text] [Related]
11. Plasma Cell Myeloma - 20-Year Comparative Survival and Mortality of Three Plasma Cell Myeloma ICD-O-3 Oncologic Phenotypes by Age, Sex, Race, Stage, Cohort Entry Time-Period and Disease Duration: A Systematic Review of 111,041 Cases for Diagnosis Years 1973-2014: (SEER*Stat 8.3.4).
Milano AF
J Insur Med; 2018; 47(4):203-211. PubMed ID: 30668210
[TBL] [Abstract][Full Text] [Related]
12. Cancer survival and incidence from the Surveillance, Epidemiology, and End Results (SEER) program.
Gloeckler Ries LA; Reichman ME; Lewis DR; Hankey BF; Edwards BK
Oncologist; 2003; 8(6):541-52. PubMed ID: 14657533
[TBL] [Abstract][Full Text] [Related]
13. Development of National Program of Cancer Registries SAS Tool for Population-Based Cancer Relative Survival Analysis.
Dong X; Zhang K; Ren Y; Wilson R; O'Neil ME
J Registry Manag; 2016; 43(2):63-73. PubMed ID: 27556840
[TBL] [Abstract][Full Text] [Related]
14. Trends in incidence rates of tobacco-related cancer, selected areas, SEER Program, United States, 1992-2004.
Polednak AP
Prev Chronic Dis; 2009 Jan; 6(1):A16. PubMed ID: 19080022
[TBL] [Abstract][Full Text] [Related]
15. Persistent socioeconomic inequalities in cancer survival in the United States: 1973-2007 surveillance, epidemiology and end results (SEER) data for breast cancer and non-Hodgkin's lymphoma.
Kato I; Booza J; Quarshie WO; Schwartz K
J Registry Manag; 2012; 39(4):158-66. PubMed ID: 23493021
[TBL] [Abstract][Full Text] [Related]
16. Retinoblastoma incidence patterns in the US Surveillance, Epidemiology, and End Results program.
Wong JR; Tucker MA; Kleinerman RA; Devesa SS
JAMA Ophthalmol; 2014 Apr; 132(4):478-83. PubMed ID: 24577366
[TBL] [Abstract][Full Text] [Related]
17. Comparing Cancer Registry Abstracted and Self-Reported Data on Race and Ethnicity.
Atekruse SF; Cosgrove C; Cronin K; Yu M
J Registry Manag; 2017; 44(1):30-3. PubMed ID: 29595942
[TBL] [Abstract][Full Text] [Related]
18. Recent cancer trends in the United States.
Devesa SS; Blot WJ; Stone BJ; Miller BA; Tarone RE; Fraumeni JF
J Natl Cancer Inst; 1995 Feb; 87(3):175-82. PubMed ID: 7707404
[TBL] [Abstract][Full Text] [Related]
19. Incidence patterns of colorectal cancers in four countries of the Middle East Cancer Consortium (Cyprus, Jordan, Israel, and İzmir, Turkey) compared with those in the United States Surveillance, Epidemiology, and End Results Program.
Eser S; Chang J; Charalambous H; Silverman B; Demetriou A; Yakut C; Nimri O; Pavlou P; Özgür S; Ziogas A; Stevens L; Ward K; Anton Culver H
Turk J Gastroenterol; 2018 Jan; 29(1):36-44. PubMed ID: 29391306
[TBL] [Abstract][Full Text] [Related]
20. Invasive Cancer Incidence and Survival--United States, 2012.
Henley SJ; Singh SD; King J; Wilson RJ; O'Neil ME; Ryerson AB
MMWR Morb Mortal Wkly Rep; 2015 Dec; 64(49):1353-8. PubMed ID: 26678069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
